Pharmaceutical composition for preventing and treating visceral white-spot disease of cynoglossus semilaevis
The invention relates to a pharmaceutical composition for preventing and treating visceral white-spot disease of cynoglossus semilaevis. The pharmaceutical composition comprises the following components in percentage by mass: 30-70% of ceftriaxone sodium and 70-30% of enrofloxacin. The pharmaceutica...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a pharmaceutical composition for preventing and treating visceral white-spot disease of cynoglossus semilaevis. The pharmaceutical composition comprises the following components in percentage by mass: 30-70% of ceftriaxone sodium and 70-30% of enrofloxacin. The pharmaceutical composition also comprises hydrogen peroxide. In the pharmaceutical composition, medicine bait for oral administration as well as a hydrogen peroxide medicated bath of proper concentration are adopted. The pharmaceutical composition is a composite and comprehensive pharmaceutical composition which can be effectively used for preventing and treating the visceral white-spot disease of cynoglossus semilaevis in the juvenile stage and adult stage and can cure the visceral white-spot disease of cynoglossus semilaevis in different regions. The pharmaceutical composition has the advantages of easiness in use, small dosage, low cost and high cure rate of 95% or over.
本发明涉及种用于防治半滑舌鳎内脏白点病的药物组合物,包括按质量百分比计的下述组分:头孢曲松钠30~70%、恩 |
---|